Ross Haghighat is Director at ADURO BIOTECH, INC. (ADRO). They have made 1 open-market trade across 1 company since 2016, most recently 2023-05-26.
CIK 0001435049
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADRO | SELL | 2016-11-14 | 2016-11-16 | $15.50 | $110K | -9.8% | -18.9% | -17.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.